Reply to: Gray et al

Movement Disorders

Volumn 29, Issue 9, 2014, Pages 1225-1226

  Visanji, Naomi P ^a   Marras, Connie ^a   Liu, Louis W C ^a   Hazrati, Lili Naz ^b   Lang, Anthony E ^a  

^a TORONTO WESTERN HOSPITAL   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA SYNUCLEIN;

COLON; HUMAN; INTESTINE INNERVATION; METABOLISM; PARKINSON DISEASE;

ALPHA-SYNUCLEIN; COLON; ENTERIC NERVOUS SYSTEM; HUMANS; PARKINSON DISEASE;

EID: 84906088648     PISSN: 08853185     EISSN: 15318257     Source Type: Journal    
DOI: 10.1002/mds.25941     Document Type: Letter

References (4)

1. Shannon KM, Keshavarzian A, Mutlu E, et al. Alpha-synuclein in colonic submucosa in early untreated Parkinson's disease. Mov Disord 2012;27:709-715.
2. Gold A, Turkalp ZT, Munoz DG. Enteric alpha-synuclein expression is increased in Parkinson's disease but not Alzheimer's disease. Mov Disord 2013;28:237-240.
3. Böttner M, Zorenkov D, Hellwig I, et al. Expression pattern and localization of alpha-synuclein in the human enteric nervous system. Neurobiol Dis 2012;48:474-480.
4. Gray MT, Munoz DG, Gray DA, Schlossmacher MG, Woulf JM. α-synuclein in the appendiceal mucosa of neurologically intact subjects. Mov Disord 2013 Dec 18. doi: 10.1002/mds.25779.